Diogo Martins-Branco
@dmbranco.bsky.social
#medonc MD 🇵🇹 & #pallonc MSc 🇬🇧 |
ESMO Scientific&Medical Division Fellow 🇨🇭 |
#research #education #policy | Views are own 🎾
ESMO Scientific&Medical Division Fellow 🇨🇭 |
#research #education #policy | Views are own 🎾
Reposted by Diogo Martins-Branco
👉 ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format.
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
July 7, 2025 at 9:30 AM
👉 ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format.
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
Reposted by Diogo Martins-Branco
📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/DSLyGib
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/DSLyGib
June 24, 2025 at 8:02 AM
📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/DSLyGib
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/DSLyGib
Reposted by Diogo Martins-Branco
📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved.
🔗 buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
June 19, 2025 at 8:02 AM
📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved.
🔗 buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
Reposted by Diogo Martins-Branco
👉 ESMO Living Guidelines on Renal Cell Carcinoma v1.1: New title with updated recommendations and algorithms from the published Guideline in an interactive format.
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
June 13, 2025 at 8:15 AM
👉 ESMO Living Guidelines on Renal Cell Carcinoma v1.1: New title with updated recommendations and algorithms from the published Guideline in an interactive format.
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
Reposted by Diogo Martins-Branco
ESMO announces the 2025 election results for the Director positions and the Nomination Committee.
Thank you to all #ESMOMembers who voted and contributed to shaping the Society’s future direction.
📢 Curious to see who was elected?
🔗 Read the full announcement: buff.ly/F1beK90
Thank you to all #ESMOMembers who voted and contributed to shaping the Society’s future direction.
📢 Curious to see who was elected?
🔗 Read the full announcement: buff.ly/F1beK90
June 14, 2025 at 8:15 AM
ESMO announces the 2025 election results for the Director positions and the Nomination Committee.
Thank you to all #ESMOMembers who voted and contributed to shaping the Society’s future direction.
📢 Curious to see who was elected?
🔗 Read the full announcement: buff.ly/F1beK90
Thank you to all #ESMOMembers who voted and contributed to shaping the Society’s future direction.
📢 Curious to see who was elected?
🔗 Read the full announcement: buff.ly/F1beK90
Reposted by Diogo Martins-Branco
📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
April 18, 2025 at 9:11 AM
📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
Reposted by Diogo Martins-Branco
🚀 ESMO is now on Bluesky
This is not an April Fools' announcement, nor is it an AI-generated post. ESMO is launching on Bluesky with a poll on AI to start the conversation.
Join us for the latest in oncology education and information.
#AIOncology #HealthAI #ESMOAI25
This is not an April Fools' announcement, nor is it an AI-generated post. ESMO is launching on Bluesky with a poll on AI to start the conversation.
Join us for the latest in oncology education and information.
#AIOncology #HealthAI #ESMOAI25
April 1, 2025 at 7:36 AM
🚀 ESMO is now on Bluesky
This is not an April Fools' announcement, nor is it an AI-generated post. ESMO is launching on Bluesky with a poll on AI to start the conversation.
Join us for the latest in oncology education and information.
#AIOncology #HealthAI #ESMOAI25
This is not an April Fools' announcement, nor is it an AI-generated post. ESMO is launching on Bluesky with a poll on AI to start the conversation.
Join us for the latest in oncology education and information.
#AIOncology #HealthAI #ESMOAI25
Reposted by Diogo Martins-Branco
Congrats to @amalsargsyan & @dmbranco.bsky.social for having abstracts selected for #oralpresentation at
#ESMORarecancers25!
Excellent work in helping community understand current issues w/ #sarcoma #clinicaltrials access & #impression of #realworldevidence for drug approvals.
#drugdevelopment
#ESMORarecancers25!
Excellent work in helping community understand current issues w/ #sarcoma #clinicaltrials access & #impression of #realworldevidence for drug approvals.
#drugdevelopment
March 20, 2025 at 5:09 PM
Congrats to @amalsargsyan & @dmbranco.bsky.social for having abstracts selected for #oralpresentation at
#ESMORarecancers25!
Excellent work in helping community understand current issues w/ #sarcoma #clinicaltrials access & #impression of #realworldevidence for drug approvals.
#drugdevelopment
#ESMORarecancers25!
Excellent work in helping community understand current issues w/ #sarcoma #clinicaltrials access & #impression of #realworldevidence for drug approvals.
#drugdevelopment
📈 #RWE publications evaluating #targetedtherapies in pts w/ #solidtumours
#RWD quality standards & ⬆️ collaboration will be 🔑 to increase the relevance of #RWE for informing clinical practice and decision making 🌍
#RWD quality standards & ⬆️ collaboration will be 🔑 to increase the relevance of #RWE for informing clinical practice and decision making 🌍
RWE is becoming increasingly vital in cancer research
To improve quality, we need to understand where we stand
Happy to share this major effort analyzing 1251 studies mapping RWE
Standardization & ⬆️ collaboration will be 🔑 to increase the relevance of RWD
@oncoalert.bsky.social
To improve quality, we need to understand where we stand
Happy to share this major effort analyzing 1251 studies mapping RWE
Standardization & ⬆️ collaboration will be 🔑 to increase the relevance of RWD
@oncoalert.bsky.social
December 5, 2024 at 7:24 AM
📈 #RWE publications evaluating #targetedtherapies in pts w/ #solidtumours
#RWD quality standards & ⬆️ collaboration will be 🔑 to increase the relevance of #RWE for informing clinical practice and decision making 🌍
#RWD quality standards & ⬆️ collaboration will be 🔑 to increase the relevance of #RWE for informing clinical practice and decision making 🌍